Trulieve Cannabis (TCNNF) director receives 23,438-share RSU grant

Rhea-AI Filing Summary

Morreau Jane Cecil reported acquisition or exercise transactions in this Form 4 filing.

Trulieve Cannabis Corp. director Jane Cecil Morreau reported an award of 23,438 Subordinate Voting Shares on 2026-03-13, recorded at $0.00 per share, bringing her reported direct holdings to 65,778 shares.

According to the footnote, this represents a grant of restricted stock units (RSUs), each equal to one Trulieve subordinate voting share. The RSUs will vest on the earliest of the end of her board service, a change of control of Trulieve, or December 1, 2032.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Morreau Jane Cecil

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Subordinate Voting Shares	23,438	$0.00	--

Holdings After Transaction: Subordinate Voting Shares — 65,778 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Morreau Jane Cecil

(Last) (First) (Middle)

C/O TRULIEVE CANNABIS CORP.

3494 MARTIN HURST ROAD

(Street)

TALLAHASSEE FL 32312

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Trulieve Cannabis Corp. [ TRUL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Subordinate Voting Shares	03/13/2026		A		23,438(1)	A	$0	65,778	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. ("Trulieve") subordinate voting share. The RSUs will vest on the earliest of (i) the end of the reporting person's service on the board of directors of Trulieve, (ii) a change of control of Trulieve, or (iii) December 1, 2032.

	/s/ Eric Powers, as Attorney-in-Fact	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Trulieve Cannabis Corp. (TCNNF) report for Jane Cecil Morreau?

Trulieve Cannabis Corp. reported that director Jane Cecil Morreau received an award of 23,438 Subordinate Voting Shares on March 13, 2026. The transaction was coded as a grant or award acquisition, not an open-market purchase or sale, reflecting equity-based compensation.

How many Trulieve (TCNNF) shares does Jane Cecil Morreau hold after this Form 4?

After the reported award, Jane Cecil Morreau’s direct holdings total 65,778 Subordinate Voting Shares. This figure comes directly from the Form 4 line "Shares owned following transaction," providing context for the relative size of the 23,438-share grant she received.

What type of equity award did Trulieve (TCNNF) grant to director Jane Cecil Morreau?

The award is a grant of restricted stock units (RSUs), each representing a contingent right to receive one Trulieve subordinate voting share. These RSUs are recorded as an acquisition of 23,438 Subordinate Voting Shares at a stated price of $0.00 per share.

When do Jane Cecil Morreau’s Trulieve (TCNNF) RSUs vest according to the Form 4?

The RSUs will vest on the earliest of three events: the end of Morreau’s service on Trulieve’s board of directors, a change of control of Trulieve, or December 1, 2032. These specific vesting triggers are detailed in the Form 4 footnote.

Was Jane Cecil Morreau’s Trulieve (TCNNF) Form 4 a buy or sell transaction?

The Form 4 shows an "A" transaction code, described as a grant, award, or other acquisition. It reflects an equity award of 23,438 shares at $0.00 per share, not an open-market buy or sell, and is categorized as an acquisition transaction.

Does the Trulieve (TCNNF) Form 4 show any derivative or option exercises for Jane Cecil Morreau?

No derivative transactions are listed in this Form 4. The derivative summary section is empty, and transaction data shows only one non-derivative acquisition entry related to the restricted stock unit award of 23,438 Subordinate Voting Shares.